| Health / Medical Topics |
Yttrium Y-90 Epratuzumab Tetraxetan
A radioimmunotherapeutic humanized murine monoclonal antibody (LL2) directed against the CD22 pan-B-cell antigen and chelated to the radioisotope yttrium-90 (Y 90). Y 90 humanized monoclonal antibody LL2 binds to tumor cells expressing CD22, delivering a cytotoxic dose of beta radiation. (NCI Thesaurus)
YOU MAY ALSO LIKE
A radioimmunoconjugate comprised of the humanized monoclonal antibody clivatuzumab, directed against the pancreatic cancer antigen MUC1, that is conjugated to the chelating…
Radioactive isotope of yttrium. A beta/gamma-emitter with a half life of 2.7 days.
A substance being studied in the treatment of some types of cancer. Yttrium Y 90-SMT 487 contains a molecule that binds to…
A radioimmunoconjugate composed of a humanized monoclonal antibody (MoAb) OTSA101 against FZD10 and labeled with yttrium y 90, with potential antineoplastic…
A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the…
A substance being studied in the treatment of certain types of B-cell cancer. Epratuzumab is a monoclonal antibody that binds to a…
